[Federal Register Volume 88, Number 23 (Friday, February 3, 2023)]
[Notices]
[Page 7394]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02264]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-9-2023]


Foreign-Trade Zone (FTZ) 46--Cincinnati, Ohio; Notification of 
Proposed Production Activity; Patheon Pharmaceuticals Inc. 
(Pharmaceutical Products), Cincinnati, Ohio

    Patheon Pharmaceuticals Inc. (Patheon) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facilities in Cincinnati, Ohio, within Subzone 46K. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on January 27, 2023.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished product is anti-diarrheal drug (active 
pharmaceutical ingredient Eluxadoline) packaged into finished dosage 
(duty free).
    The proposed foreign-status materials and components include active 
pharmaceutical ingredient Eluxadoline and mannitol (duty rates, 6.5% 
and 4.6%, respectively). The request indicates that the materials/
components are subject to duties under Section 301 of the Trade Act of 
1974 (Section 301), depending on the country of origin. The applicable 
Section 301 decisions require subject merchandise to be admitted to 
FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is March 15, 2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: January 30, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-02264 Filed 2-2-23; 8:45 am]
BILLING CODE 3510-DS-P